Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

HYOPLUS

Class 5Status: Accepted & Advertised
Application Number5897460
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2023-04-18
Proprietor NamePHARMAC DRUGS PRIVATE LIMITED
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User DetailsProposed to be used
Agent NameJITENDRA JAIN[33315]
Agent AddressWZ-22, 4TH FLOOR, NIMRI VILLAGE, SHASTRI NAGAR DELHI-110052.
Goods And Services Details[CLASS : 5] Medicinal and Pharmaceutical Preparation

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
HYOPLUS5Accepted & Advertised
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about HYOPLUS.

What is the status of trademark application 5897460?
The current status of trademark application 5897460 for HYOPLUS is Accepted & Advertised.
What is the trademark class of HYOPLUS?
HYOPLUS is registered under trademark class 5.
Who is the proprietor of HYOPLUS?
The proprietor of HYOPLUS is PHARMAC DRUGS PRIVATE LIMITED.
When was trademark application 5897460 filed?
Trademark application 5897460 for HYOPLUS was filed on 2023-04-18.